Sources | Names Used |
---|---|
CTRPv2 | navitoclax:sorafenib (1:1 mol/mol) |
PharmacoGx | navitoclax:sorafenib (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF92 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ZNF93 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | ZSCAN12 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
mRNA | ZSCAN18 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
mRNA | ZSCAN30 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | ZSCAN5A | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | ZSCAN9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZXDC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |